Globus Medical 

€62
73
+€0+0% 今天

統計

當日最高
62
當日最低
61
52週最高
-
52週最低
-
成交量
100
平均成交量
-
市值
9.91B
市盈率
243.68
股息收益率
-
股息
-

即將到來

收益

5Nov確認
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
Q2 2024
下一個
0.51
0.59
0.67
0.75
預期每股收益
0.648
實際每股收益
N/A

人們還關注

此列表基於在 Stock Events 上關注 GM0N.F 的人的關注列表。這不是投資建議。

競爭者

這個列表是基於最近市場事件的分析。這不是投資建議。

分析師評級

78平均價格目標
最高估價為 €93。
來自過去 6 個月內的 9 個評級。這不是投資建議。
買入
67%
持有
33%
賣出
0%

關於

Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative and congenital conditions, deformity, tumors, and trauma injuries; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. It also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, the company distributes human cell, tissue, and cellular and tissue-based products. It sells its products through direct or distributor sales representatives, as well as hip and knee products through independent sales agents. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.
Show more...
首席執行官
Mr. David C. Paul
員工
5000
國家
US
ISIN
US3795772082
WKN
000A1J2LY

上市公司